Ultimovacs announces a new clinical study in lung cancer.
Author Archive for: oslocancer
This author has yet to write their bio.Meanwhile lets just say that we are proud oslocancer contributed a whooping 523 entries.
Entries by oslocancer
Eli Lilly & Company is now part of the national Norwegian IMPRESS study.
Statsbudsjettet for 2022 inneholder lite for kreftpasienter og innovasjon innen kreftbehandling.
Did you know that Oslo Cancer Cluster is a changemaker?
Contact us >
Oslo Cancer Cluster Innovation Park opened in May 2015.
The Innovation Park brings together the oncology-value chain from basic research to industry within the Oslo-area.
Our vision is to create Europe's leading environment for education, research and industry within oncology, shortening the development time of new cancer treatments.